PubRank

Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26232159)

Published in Clin Chim Acta on July 29, 2015

Authors

Michele Mussap1, Elisabetta Puxeddu2, Melania Puddu2, Giovanni Ottonello2, Ferdinando Coghe3, Paola Comite4, Francesco Cibecchini4, Vassilios Fanos5

Author Affiliations

1: Laboratory Medicine Service, IRCCS AOU San Martino-IST, University-Hospital, National Institute for Cancer Research, Genova, Italy. Electronic address: michele.mussap@hsanmartino.it.
2: Neonatal Intensive Care Unit, Neonatal Pathology, Puericulture Institute and Neonatal Section, Azienda Ospedaliera Universitaria, Cagliari, Italy.
3: Laboratory Medicine Service, Azienda Ospedaliera Universitaria, Cagliari, Italy.
4: Laboratory Medicine Service, IRCCS AOU San Martino-IST, University-Hospital, National Institute for Cancer Research, Genova, Italy.
5: Neonatal Intensive Care Unit, Neonatal Pathology, Puericulture Institute and Neonatal Section, Azienda Ospedaliera Universitaria, Cagliari, Italy; Department of Surgical Sciences, University of Cagliari, Italy.

Articles citing this ↘

AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital. J Thorac Dis (2016) 0.89

Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates. PLoS One (2015) 0.81

Presepsin for the detection of early-onset sepsis in preterm newborns. Pediatr Res (2016) 0.75

Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings. Lab Chip (2017) 0.75